Manikandan Periyasamy

Author

Imperial College London ORCID

Also Known As

M Periyasamy, M. Periyasamy, Manikandan Periyasamy, Periyasamy Manikandan, Periyasamy, Manikandan

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Imperial College London Hammersmith Hospital Ninewells Hospital University of Dundee Cancer Research UK

About

Manikandan Periyasamy is an author at Imperial College London specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	544
2	Cell Biology	9	9	544
3	Engineering	1	1	113
4	Immunology	1	1	22
5	Molecular Biology	1	1	84

Manikandan Periyasamy

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer Alison Harrod, J Fulton, Van T.M. Nguyen, Oncogene	2016	174
The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity Simak Ali, Dean A. Heathcote, Sebastian H. B. Kroll, Cancer Research	2009	162
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment Hetal Patel, Manikandan Periyasamy, Georgina P. Sava, Molecular Cancer Therapeutics	2018	138
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion Van T.M. Nguyen, Iros Barozzi, Monica Faronato, Nature Communications	2015	134
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer Manikandan Periyasamy, Hetal Patel, Chun‐Fui Lai, Cell Reports	2015	115
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts Loredana Pellegrino, Justin Stebbing, Vania Braga, Nucleic Acids Research EngineeringCell ProliferationCancer BiologyTumor BiologyCancer Cell Biology	2013	113
The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer NC Wortham, Eliyaz Ahamed, Samantha M. Nicol, Oncogene Tumor BiologyTranscriptional RegulationBreast OncologySignaling PathwayMedicine	2009	110
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases Jorge López‐García, Manikandan Periyasamy, Ross S. Thomas, Nucleic Acids Research	2006	106
Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo Ylenia Lombardo, Aleksandra Filipović, Gemma Molyneux, Proceedings of the National Academy of Sciences	2012	103
A Novel Pyrazolo[1,5-<i>a</i>]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration Dean A. Heathcote, Hetal Patel, Sebastian H. B. Kroll, Journal of Medicinal Chemistry	2010	99

Page 1